Navigation

'Referral advice' recommendation details

Chronic obstructive pulmonary disease (updated)

Results 1-10 of 13

Guidance ID NICE 'referral advice' recommendation 'Referral advice' category
CG101 Patients identified as having alpha-1 antitrypsin deficiency should be offered the opportunity to be referred to a specialist centre to discuss the clinical management of this condition. Time frame not specified
CG101 If diagnostic uncertainty remains in patients with suspected chronic obstructive pulmonary disease (COPD) following reversibility testing, referral for more detailed investigations, including imaging and measurement of transfer factor for carbon monoxide [TLCO], should be considered. Time frame not specified
CG101 It is recommended that referrals for specialist advice are made when clinically indicated in patients with chronic obstructive pulmonary disease (COPD). Referral may be appropriate at all stages of the disease and not solely in the most severely disabled patient. Patients who are referred do not always have to be seen by a respiratory physician. In some cases they may be seen by members of the chronic obstructive pulmonary disease (COPD) team who have appropriate training and expertise. Time frame not specified
CG101 Adequately treated patients with chronic hypercapnic respiratory failure who have required assisted ventilation (whether invasive or non-invasive) during an exacerbation or who are hypercapnic or acidotic on Long-term oxygen therapy (LTOT) should be referred to a specialist centre for consideration of long-term Non-invasive ventilation. Time frame not specified
CG101 Multidisciplinary management is recommended in patients with chronic obstructive pulmonary disease (COPD). Many of these activities may be undertaken in the clinic or in the practice as part of routine care by the practitioner seeing the patient but in certain circumstances the patient may need to be referred to a specialist department, for example, physiotherapy. Time frame not specified
CG101 Body mass index (BMI) should be calculated in patients with chronic obstructive pulmonary disease (COPD): the normal range for body mass index (BMI) is 20 to less than 25, if the body mass index (BMI) is abnormal (high or low), or changing over time, the patient should be referred for dietetic advice. Time frame not specified
CG101 Ambulatory oxygen therapy should only be prescribed after an appropriate assessment has been performed by a specialist. Time frame not specified
CG101 Scuba diving is not generally recommended for patients with chronic obstructive pulmonary disease (COPD). Advise people with queries to seek specialist advice. Time frame not specified
CG101 Clinicians involved in the care of people with chronic obstructive pulmonary disease (COPD) should assess their need for occupational therapy using validated tools. Time frame not specified
CG101 Follow-up of all patients with chronic obstructive pulmonary disease (COPD) should include: - highlighting the diagnosis of chronic obstructive pulmonary disease (COPD) in the case record and recording this using Read codes on a computer database - recording the values of spirometric tests performed at diagnosis (both absolute and percent predicted) - offering smoking cessation advice - recording the opportunistic measurement of spirometric parameters. Opportunistic measurements of spirometric parameters should be recorded and reviewed as a loss of 500 ml or more over 5 years may indicate rapidly progressing disease. These patients should be considered for specialist referral and investigation. Follow up

This page was last updated: 22 August 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.